OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.23 USD
-0.02 (-1.60%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $1.22 -0.01 (-0.81%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth F Momentum F VGM
Income Statements
Fiscal Year end for OPKO Health, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 864 | 1,004 | 1,775 | 1,435 | 902 |
Cost Of Goods | 545 | 716 | 1,193 | 894 | 572 |
Gross Profit | 318 | 288 | 582 | 541 | 329 |
Selling & Adminstrative & Depr. & Amort Expenses | 475 | 514 | 563 | 483 | 604 |
Income After Depreciation & Amortization | -157 | -226 | 19 | 58 | -274 |
Non-Operating Income | -14 | -153 | -14 | 13 | -9 |
Interest Expense | 14 | 12 | 19 | 22 | 22 |
Pretax Income | -184 | -392 | -14 | 49 | -305 |
Income Taxes | 4 | -64 | 15 | 18 | 7 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | -1 | 0 | -3 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -189 | -328 | -30 | 31 | -315 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -189 | -328 | -30 | 31 | -315 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -50 | -116 | 98 | 144 | -179 |
Depreciation & Amortization (Cash Flow) | 107 | 110 | 80 | 86 | 95 |
Income After Depreciation & Amortization | -157 | -226 | 19 | 58 | -274 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 751.72 | 719.06 | 648.08 | 640.66 | 595.45 |
Diluted EPS Before Non-Recurring Items | -0.25 | -0.36 | -0.05 | 0.05 | -0.41 |
Diluted Net EPS (GAAP) | -0.25 | -0.46 | -0.05 | 0.05 | -0.53 |
Fiscal Year end for OPKO Health, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 181.91 | 178.60 | 265.42 | 237.58 |
Cost Of Goods | NA | 137.20 | 130.92 | 138.94 | 138.31 |
Gross Profit | NA | 44.71 | 47.68 | 126.48 | 99.26 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 113.75 | 112.09 | 119.46 | 129.86 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -69.04 | -64.41 | 7.02 | -30.60 |
Non-Operating Income | NA | 0.00 | -10.59 | -20.20 | 16.99 |
Interest Expense | NA | 3.45 | 3.38 | 3.28 | 3.39 |
Pretax Income | NA | -72.49 | -78.38 | -16.45 | -17.00 |
Income Taxes | NA | -6.02 | 6.08 | 3.15 | 1.23 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | -0.01 | -0.02 | -0.04 | -0.04 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -66.48 | -84.47 | -19.64 | -18.27 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -66.48 | -84.47 | -19.64 | -18.27 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 751.51 | 751.53 | 751.73 | 751.51 |
Diluted EPS Before Non-Recurring Items | NA | -0.09 | -0.11 | -0.03 | -0.02 |
Diluted Net EPS (GAAP) | NA | -0.09 | -0.11 | -0.03 | -0.02 |